enzymes are known to detoxify and/or toxify these compounds into metabolites that are more polar and sometimes more reactive 6 10 . There is no literature on the absorption or excretion of -terpinen-4-ol in the human body. Therefore, it would be interesting to examine how cytochrome P450 CYP or P450 enzymes in human liver microsomes metabolize -terpinen-4-ol. It has been reported that Spodoptera litura a species of caterpillar catalyzes the conversion of -and -terpinen-4-ol to -and -p-menth-1-en-4,7-diol 11 .
Gibberella cyanea DSM 62719 has been shown to metabolize enantiomeric -terpinen-4-ol to 3 oxidized metabo-lites: 1S,2S,4S -p-menthan-1,2,4-triol, 6-p-menthen-2,4-diol, and 1R,2R,4S -2-hydroxy-1,4-cineol 12 . However, there have been no reports on the biotransformation of -terpinen-4-ol by human liver microsomes. We have previously demonstrated that several monoterpenoids, including 1,4-and 1,8-cineole, -and -limonenes, -fenchone, and -and -menthols are metabolized by P450 enzymes in human liver microsomes 13 17 .
1,4-Cineole and 1,8-cineole have been reported to be oxidized at position 2 by human CYP3A4 enzymes 13, 14 . Limonene enantiomers are metabolized to their respective carveols and perillyl alcohols in human liver 15 , -fenchone is oxidized to 6-endo-hydroxyfenchone, 6-exo-hydroxyfenchone, and 10-hydroxyfenchone derivatives by human CYP2A6 and CYP2B6 16 , and -and -menthols are oxidized at position 8 by human CYP2A6 17 .
In the current study, we examined the oxidation of -terpinen-4-ol by P450 enzymes in liver microsomes prepared from different human liver samples, and analyzed the resulting metabolites by gas chromatography-mass spectrometry GC-MS . We also examined the metabolism of -terpinen-4-ol by human liver microsomes and recombinant human P450 enzymes expressed in insect cells into which both human P450 and NADPH-P450 reductase cDNAs had been introduced.
EXPERIMENTAL PROCEDURES

Chemicals
-Terpinen-4-ol was purchased from Tokyo Chemical Industry Co., Ltd. Tokyo, Japan . Terpinolene and -menthofuran were purchased from Fluka Tokyo, Japan . α-Naphthofl avone and ketoconazole were purchased from Sigma-Aldrich St. Louis, MO, USA . We purchased NADP , glucose 6-phosphate, and glucose 6-phosphate dehydrogenase from Oriental Yeast, Ltd. Tokyo, Japan . Other regents and chemicals used in this study were obtained from sources as identified above of the highest quality commercially available. As indicated below, -1R,2S,4S -1,2-epoxy-p-menthan-4-ol and -1S,2R,4S -1,2-epoxy-p-menthan-4-ol were synthesized in a general manner with meta-chloroperoxybenzoic acid mCPBA , and p-menth-1-en -4,8- 2.2 Synthesis of + -1R,2S,4S -1,2-epoxy-p-menthan-4-ol and + -1S,2R,4S -1,2-epoxy-p-menthan-4-ol -Terpinen-4-ol 500 mg , mCPBA 1.3 equiv , and NaHCO 3 2 equiv were added to dichloromethane 6 mL on ice for 30 min. The dichloromethane solvent was evaporated. The remaining organics were dissolved in diethyl ether and washed with a Na 2 CO 3 solution and a brine solution. The organic layer was separated, dried over sodium sulfate Na 2 SO 4 , fi ltered, and evaporated to yield a crude product 588.1 mg . Column chromatography over silica gel hexane-EtOAc gradient as eluent yielded -1R,2S,4S -1,2-epoxy-p-menthan-4-ol 209.4 mg and -1S,2R,4S -1,2-epoxy-p-menthan-4-ol 101.0 mg .
Biotransformation of + -terpinen-4-ol by G. cingulata
and isolation of the metabolites Spores of G. cingulata, which had been preserved at low temperature, were inoculated into sterilized culture medium 1.5 saccharose, 1.5 glucose, 0.5 polypeptone, 0.05 MgSO 4 7H 2 O 2 , 0.05 KCl, 0.1 K 2 HPO 4 , 0.001 FeSO 4 7H 2 O and distilled water, pH 7.2 in a shaking fl ask at 27 for 5 days. The precultured G. cingulata were transferred into a 1200 mL stirred incubation fl ask. Cultivation was carried out at 27 with stirring for 3 days under aeration.
-Terpinen-4-ol 360 mg was then added to the culture medium and the incubation continued for 7 days. After the biotransformation, the culture medium and mycelia were separated by fi ltration. The medium was salted out with NaCl and extracted with diethyl ether. The mycelia were also extracted with diethyl ether. The diethyl ether extracts were mixed and dried over Na 2 SO 4 and the solvent was evaporated to yield the crude extract. The extract was chromatographed on silica-300 columns with hexane-EtOAc and p-menth-1-en-4,8-diol 42.8 mg was isolated.
Enzymes
Ten human liver microsomes HG-03, HG-06, HG-74, HG-88, HH-13, HH-18, HH-47, HH-74, HK-37, HG-18 were obtained from Gentest Corp. Woburn, MA, USA and stored at 80 . The microsomes were accompanied by complete catalytic assays of the major CYPs: phenacetin-Odeethylase CYP1A2 , coumarin 7-hydroxylase CYP2A6 , S -mephenytoin N-demethylase CYP2B6 , paclitaxel 6α-hydroxylase CYP2C8 , 4 -hydroxylase CYP2C9 , S -mephenytoin 4 -demethylase CYP2C19 , bufuralol 1 -hydroxyase CYP2D6 , chlorzoxazone 6-hydroxylase CYP2E1 , testosterone 6β-hydroxylase CYP3A4 , and lauric acid 12-hydroxylase CYP4A . Recombinant human CYP1A1, 1A2, 1B1, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4 expressed in Trichoplusia ni insect cells infected with a baculovirus containing P450 and NADPH-P450 reductase cDNA inserts were obtained from Gentest. The CYP activities in the human liver microsomes were assessed as indicated by the manufacturer.
Instrumentation
GC-MS analysis was performed on an Agilent 6890N Gas Chromatograph Agilent Technologies, Santa Clara, CA, USA equipped with an Agilent 5973N quadrupole mass selective detector. The metabolites were separated with a HP-5MS nonpolar capillary column 30 m 0.25 mm i.d., fi lm thickness 0.25 mm Agilent Technologies, Santa Clara, CA, USA using helium at 1.5 mL min 1 as the carrier gas.
The column temperature was programmed as isothermal at 80 for 3 min, raised to 270 at a rate of 4 min 1 , and held at 270 for 5 min. The injector temperature was maintained at 270 . GC column effluent was introduced directly into the ion source via a transfer line 280 . The ion source temperature was set at 230 . The electron impact EI ionization voltage was set to 70 eV and positivecharge ions were analyzed in full-scan mode, applying a scan of m/z 40-300 amu. The NMR spectra were obtained on a JEOL ECA-400 spectrometer 400 MHz, 1 H; 100 MHz, 13 C . Samples were dissolved in dimethyl sulfoxide and CDCl 3 for 1 H-NMR spectra. Residual dimethyl sulfoxide and CDCl 3 were used as an internal standard 2.50 and 7.70 ppm for 13 C-NMR spectra measured in dimethyl sulfoxide-d 6 and CDCl 3 .
In vitro assay with human liver microsomes
The metabolism of -terpinen-4-ol by human liver microsomes was assayed with a standard reaction mixture containing liver microsomes 0.2 mg protein mL 1 with 200 μM -terpinen-4-ol in methanol at less than 1 v/v in a fi nal solvent concentration in a fi nal volume of 0.5 mL of 100 mM potassium phosphate buffer pH 7.4 containing an NADPH-generating system 0.5 mM NADP , 5 mM glucose 6-phosphate, and 0.5 units of glucose 6-phosphate dehydrogenase mL 1 . The incubation was carried out at 37
for 60 min and terminated by adding 1.5 mL of dichloromethane. The reaction mixture was mixed vigorously and the extracts organic layer collected by centrifugation at 3000 rpm for 5 min. The organic layer was transferred to an insert for GC-MS analysis.
2.7
In vitro assay with cDNA-expressed P450 enzymes Microsomes from T. ni cells expressing 11 individual human P450 enzymes were used. The reactions were carried out as described in Section 2.6. To examine the role of individual recombinant P450 enzymes involved in the metabolism of -terpinen-4-ol, each of the 11 recombinant P450 enzymes 20 nM was incubated with 200 μM substrate for 60 min at 37 .
Inhibition experiments
The inhibitory effects of known P450 enzyme-selective inhibitors on the metabolism of -terpinen-4-ol by human liver microsomes and recombinant P450 enzymes were evaluated to determine which P450 enzymes are involved in each metabolic pathway. The specifi c inhibitors used in this study were 2.5-20 μM α-naphthofl avone, a selective CYP1A2 inhibitor 18, 19 ; 2.5-20 μM -menthofuran, a selective CYP2A6 inhibitor 19, 20 ; and 2.5-20 μM ketoconazole, a selective CYP3A4 inhibitor 19 . Inhibition experiments contained 20 nM recombinant P450 enzyme, an inhibitor, 100 mM phosphate buffer pH 7.4 , and an NADPHgenerating system prior to the addition of 100 μM substrate. The reaction was carried out as described in Section 2.6.
Kinetic analysis
The kinetic parameters V max and K m for -terpinen-4-ol metabolite formation by recombinant human P450 enzymes were estimated using a computer program designed for nonlinear regression analysis. Substrate concentrations used for the analysis of metabolism of -terpinen-4-ol were 10, 30, 50, 100, 200, and 400 μM. 
Correlation test
We used the 10 human liver microsomes to determine the activities of -terpinen-4-ol metabolite formation and to compare these activities with those of known CYP1A2-, CYP2A6-and CYP3A4-catalyzed marker reactions in these microsomal preparations.
Blank tests
Incubation was carried out at 37 for 60 min with 200 μM substrate in methanol at less than 1 v/v in final solvent concentration in a final volume of 0.5 mL of 100 mM potassium phosphate buffer pH 7.4 in combination with the NADPH-generating system but without the addition of microsomes. Three metabolites were not performed.
RESULTS
Identification of + -terpinen-4-ol metabolites follow-
ing incubation with human liver microsomes -Terpinen-4-ol was incubated with a human liver mi-crosome HH-18 in the presence of an NADPH-generating system, and we analyzed the resulting products by GC-MS Fig. 1 and Fig. 2 . The identities of -terpinen-4-ol metabolites peaks 1, 2, and 3 were suggested from the following lines of evidence derived from GC-MS analysis: 
Oxidation of
-terpinen-4-ol by recombinant P450 enzymes We tested 11 human recombinant P450 enzymes expressed in T. ni cells for their ability to catalyze the formation of 3 metabolites. CYP1A2, CYP2A6, and CYP3A4 catalyzed oxidation of -terpinen-4-ol to -1S,2R,4S -1,2-epoxy-p-menthan-4-ol Fig. 3 . We found that -1R,2S,4S -1,2-epoxy-p-menthan-4-ol formation was catalyzed by CYP2A6 and CYP3A4 activity. Only CYP2A6 catalyzed the oxidation of -terpinen-4-ol to 4S -p-menth-1-en-4,8-diol. Other P450 enzymes, including CYP1A1, CYP1B1, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP2E1, had very low activities or activities below the limit of detection.
Inhibitions of + -terpinen-4-ol metabolism by chemi-
cal inhibitors for CYP1A2, CYP2A6, and CYP3A4 To further assess whether the different metabolic pathways of -terpinen-4-ol were catalyzed by CYP1A2, CYP2A6, and CYP3A4, we examined the effects of chemical inhibitors of CYP1A2 α-naphthoflavone , CYP2A6 -menthofuran , and CYP3A4 ketoconazole on -terpinen-4-ol metabolism by the human liver microsome HH-18 and recombinant P450 enzymes. HH-18 contained relatively high activity of CYP1A2, CYP2A6, and CYP3A4. The optimal concentrations of α-naphthoflavone, -menthofuran, and ketoconazole needed to inhibit their respective oxidations of -terpinen-4-ol effectively were determined using recombinant CYP1A2, CYP2A6, and CYP3A4. The results of these experiments are shown in Fig. 4A, 4C , and 4E, respectively. In the recombinant assays, α-naphthoflavone, -menthofuran, and ketoconazole strongly inhibited the oxidation of -terpinen-4-ol by CYP1A2, CYP2A6, and CYP3A4, respectively. The results of the inhibition by various concentrations of chemical inhibitors on the metabolism of -terpinen-4-ol by HH-18 are shown in Fig. 4B, 4D , and 4F.
-Menthofuran and ketoconazole inhibited oxidation by more than 50 in HH-18, whereas α-naphthofl avone did not exhibit inhibitory effects than -menthofuran and ketoconazole.
3.4 Kinetic analysis of + -terpinen-4-ol oxidation by recombinant human P450 enzymes Kinetic analysis of -terpinen-4-ol oxidation activities was carried out using recombinant CYP1A2, CYP2A6, and CYP3A4 Table Table 1 Kinetic analysis of the oxidation of (+)-terpinen-4-ol by human liver microsomes and recombinant human P450 enzymes expressed in T. ni cells.
Enzyme source
Oxidation of (+)-Terpinen-4-ol 71.9 nmol min 1 nmol 1 P450.
3.5 Correlations of + -terpinen-4-ol oxidation with selective P450 activities The above results suggest that CYP1A2, CYP2A6, and CYP3A4 are important enzymes in -terpinen-4-ol oxidation by human liver microsomes. Figure 5 depicts the relationship between the oxidation activity of -terpinen-4-ol and specific activities for CYP1A2, CYP2A6, and CYP3A4 in 10 individual human liver microsomes. There was a good correlation between -1S,2R,4S -1,2-epoxy-p-menthan-4-ol formation and CYP3A4 activity r 0.869 , and 4S -p-menth-1-en-4,8-diol formation and CYP2A6 activity r 0.951 . The formation rates of -1R,2S,4S -1,2-epoxy-p-menthan-4-ol correlated slightly with the activities of CYP2A6 and CYP3A4. There was no correlation between CYP1A2 activity and the formation of -1S,2R,4S -1,2-epoxy-p-menthan-4-ol.
DISCUSSION
The present study investigated the metabolism of -terpinen-4-ol by human liver microsomal P450 enzymes. Human liver microsomes converted -terpinen-4-ol to -1 R ,2S ,4S -1,2-epoxy-p -menthan-4-ol, -1S,2R,4S -1,2-epoxy-p-menthan-4-ol, and 4S -p-menth-1-en-4,8-diol Fig. 6 . Two absolute stereostructures of position 4 of p-menth-1-en-4,8-diol are known. However, we believe that the steric structure of position 4 is not changed because the substrate is -4S -terpinen-4-ol and oxidation takes place at position 8.
Human recombinant CYP2A6 and CYP3A4 were identified as major enzymes involved in 4S -p-menth-1-en-4,8-diol and -1S,2R,4S -1,2-epoxy-p-menthan-4-ol formation by human liver microsomes according to the following lines of evidence. Ketoconazole signifi cantly inhibited -terpinen-4-ol oxidation, and there was a good correlation between -1S,2R,4S -1,2-epoxy-p-menthan-4-ol and CYP3A4 activity in the 10 human liver microsomes. There was also a good correlation between 4S -p-menth-1-en-4,8-diol and CYP2A6 activity in the liver microsomes.
Kinetic analysis showed that the V max /K m values for the oxidation of -terpinen-4-ol to -1R,2S,4S -1,2-epoxy-p-menthan-4-ol, -1S,2R,4S -1,2-epoxy-p-menthan-4-ol, and 4S -p-menth- ly. These results suggested that CYP2A6 and CYP3A4 are major enzymes in -terpinen-4-ol hydroxylation in the human liver. We believe that -terpinen-4-ol is metabolized by CYP2A6 and CYP3A4 in human liver microsomes, with CYP2A6 playing a more important role than CYP3A4. The V max /K m value in human liver microsomes and V max /K m value of CYP2A6 demonstrate that the value of 4S -pmenth-1-en-4,8-diol is relatively higher CYP1A2 and CYP3A4. Therefore, we determined that CYP2A6 was the more important enzyme in the oxidation of -terpinen-4-ol by human liver microsomes.
We have previously reported that naturally occurring 1,4-and 1,8-cineole, -and -limonene enantiomers,
Fig. 6
Metabolism of (+)-terpinen-4-ol by human liver microsomes.
-fenchone, and -and -menthols are metabolized by different forms of P450 enzymes in humans. In humans, 1,4-and 1,8-cineole are both principally oxidized by CYP3A4. CYP2C9 and CYP2C19 metabolize -and -limonene, respectively, -fenchone is oxidized by CYP2A6 and CYP2B6, and -and -menthols are metabolized by CYP2A6.
It has been reported that several biocatalysts biotransform various monoterpenoids, including -terpinen-4-ol. We have previously shown that S. litura metabolizes -terpinen-4-ol to -p-menth-1-en-4,7-diol. 11 G. cyanea DSM 62719 has been shown to metabolize enantiomeric -terpinen-4-ol to 3 oxidized metabolites: 1S,2S,4S -pmenthan-1,2,4-triol, 6-p-menthen-2,4-diol, and 1R,2R,4S -2-hydroxy-1,4-cineol 12 . In this study, human liver microsomes converted -terpinen-4-ol to -1R,2S,4S -1,2-epoxy-p-menthan-4-ol, -1S,2R,4S -1,2-epoxy-pmenthan-4-ol, and 4S -p-menth-1-en-4,8-diol. Therefore, our results show that metabolism of -terpinen-4-ol by human liver microsomes is different from that of S. litura and G. cyanea DSM 62719.
In summary, the current results demonstrate that in human liver microsomes, -terpinen-4-ol is converted to -1S,2R,4S -1,2-epoxy-p-menthan-4-ol by CYP1A2, CYP2A6, and CYP3A4, to -1R,2S,4S -1,2-epoxy-pmenthan-4-ol by CYP2A6 and CYP3A4, and to 4S -p-menth-1-en-4,8-diol by CYP2A6. CYP2A6 and CYP3A4 are thought to be principal enzymes in human liver microsomes. Therefore, we believe that -terpinen-4-ol is metabolized by CYP2A6 and CYP3A4 in human liver microsomes, with CYP2A6 playing a more important role than CYP3A4.
